Liu Chengyi, Xu Pengcheng, Shao Song, Yang Mingshan, Li Chao, Li Shuangjie, Liu Wei, Ding Xiaobo, Ma Jici, Li Guangyuan
Department of Urology, LU'AN Affiliated Hospital of Anhui Medical University, Lu'an, Anhui, China.
Department of Orthopaedic, LU'AN Affiliated Hospital of Anhui Medical University, Lu'an, Anhui, China.
Front Med (Lausanne). 2023 Mar 9;10:1139986. doi: 10.3389/fmed.2023.1139986. eCollection 2023.
Exploratory study of the effect and clinical value of carbon nanoparticle suspension injection (CNSI) as a tracer for inguinal sentinel lymph nodes in penile cancer.
We selected 29 patients with penile cancer in our department from January 2019 to October 2022. According to whether the CNSI tracer was injected during the pathological biopsy of the inguinal lymph nodes, the enrolled patients were assigned to the control group, the group in which CNSI was injected 12 h before the surgery (12HBS group) and the group in which CNSI was injected 0.5 h before the surgery (0.5HBS group). Evaluating the effectiveness of CNSI as a lymphatic tracer involves analyzing the following: its safety, the statistical analysis of the detection rate (DR) of different groups, the number of lymph nodes sent for each case (NOLNSFEC), the difference of positive rate of lymphatic metastasis (PROLM), and operation time (OT).
The lymph nodes in the 12HBS group and 0.5HBS group had an obvious black staining appearance, and no adverse reactions or surgical complications were found. Most of the black-stained areas caused by CNSI injection were removed with penile excision, which did not affect the postoperative appearance. This did not affect the pathological analysis. The DR of lymph nodes in the 12HBS group was higher ( < 0.05) than that in the control group. More lymph nodes were removed for examination ( < 0.05), which improved the efficiency of surgery. Compared with the 12HBS group, the number of lymph nodes removed in the 0.5HBS group decreased ( < 0.05). The OT was shortened ( < 0.05), but there was no significant difference in the DR and PROLM.
CNSI was applied to the naked-eye tracing of inguinal sentinel lymph nodes in penile cancer, which is safe and efficient. Injection of CNSI 0.5 h before surgery can help identify the "foremost position" of sentinel lymph nodes and reduce surgical trauma.
探索碳纳米颗粒混悬液注射(CNSI)作为阴茎癌腹股沟前哨淋巴结示踪剂的效果及临床价值。
选取2019年1月至2022年10月在我科就诊的29例阴茎癌患者。根据腹股沟淋巴结病理活检时是否注射CNSI示踪剂,将入选患者分为对照组、术前12小时注射CNSI组(12HBS组)和术前0.5小时注射CNSI组(0.5HBS组)。评估CNSI作为淋巴示踪剂的有效性包括分析以下内容:其安全性、不同组别的检出率(DR)的统计学分析、每例送检淋巴结数量(NOLNSFEC)、淋巴转移阳性率(PROLM)的差异以及手术时间(OT)。
12HBS组和0.5HBS组的淋巴结有明显的黑色染色外观,未发现不良反应或手术并发症。CNSI注射引起的大部分黑色染色区域随阴茎切除一并切除,不影响术后外观,也不影响病理分析。12HBS组淋巴结的DR高于对照组(<0.05)。送检淋巴结数量更多(<0.05),提高了手术效率。与12HBS组相比,0.5HBS组切除的淋巴结数量减少(<0.05)。OT缩短(<0.05),但DR和PROLM无显著差异。
CNSI应用于阴茎癌腹股沟前哨淋巴结的肉眼示踪,安全有效。术前0.5小时注射CNSI有助于识别前哨淋巴结的“首要位置”并减少手术创伤。